Personalized Medicine in Multiple Myeloma: The Latest Treatment Advancements

preview_player
Показать описание
Learn about different applications of personalized medicine in multiple myeloma, including genomics and immunotherapy, from experts in the field, including Bristol Myers Squibb’s Kristen Hege, M.D., Senior Vice President, Early Clinical Development, Oncology/Hematology and Cell Therapy, MMRF’s Mary DeRome, MSc, Senior Director, Education and Medical Communications, and 2seventy bio’s Anna Truppel-Hartmann, M.D., Vice President, Oncology Clinical Development.

Join Bristol Myers Squibb online:
Рекомендации по теме